RadNet Reports Record Q4 Revenue & EBITDA, Exceeds 2025 Guidance, and Issues Strong 2026 Outlook
RDNT sits 67% above its 52-week low of $45.001.
Summary
RadNet, Inc. announced record fourth quarter and full-year 2025 revenue and Adjusted EBITDA, surpassing its own guidance, and provided robust 2026 financial projections driven by strong imaging center performance and strategic growth in its Digital Health segment.
Key Events · Earnings and Guidance · RDNT
-
Record Q4 & FY 2025 Financials
RadNet reported record fourth quarter 2025 revenue of $547.7 million (up 14.8%) and Adjusted EBITDA of $87.7 million (up 16.9%). Full-year 2025 revenue reached $2.04 billion and Adjusted EBITDA was $300.2 million.
-
Exceeded 2025 Guidance
The company surpassed its previously upwardly revised 2025 guidance levels for both Imaging Center segment revenue and Adjusted EBITDA.
-
Strong 2026 Financial Guidance
RadNet issued robust 2026 guidance, projecting Imaging Center segment revenue growth of 17%-19% and Adjusted EBITDA growth of 18%-22%. Digital Health revenue is anticipated to grow 46%-56%.
-
Digital Health Strategic Growth
The Digital Health segment is set for accelerated growth, bolstered by the acquisition of Gleamer and expectations for a minimum of four FDA clearances in 2026, expanding its AI solutions portfolio.
Analysis · RDNT · Industrial Applications And Services
RadNet, Inc. delivered a strong financial performance, reporting record fourth quarter and full-year 2025 revenue and Adjusted EBITDA, which exceeded its previously raised guidance. The company's robust 2026 financial guidance, particularly the significant growth projected for its Digital Health segment, indicates positive momentum. While the company reported a GAAP net loss for both the fourth quarter and full year 2025, management highlighted that this was impacted by unusual or one-time items, emphasizing the strength of adjusted metrics and operational growth. The strategic acquisition of Gleamer and anticipated FDA clearances for AI solutions in Digital Health are key drivers for future growth and market leadership.
At the time of this filing, RDNT was trading at $75.01 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.4B. The 52-week trading range was $45.00 to $85.84. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.